Status:

COMPLETED

Prospective Evaluation Analysis and Kinetics Registry

Lead Sponsor:

University of Utah

Collaborating Sponsors:

AltaThera Pharmaceuticals, LLC

Conditions:

Atrial Arrhythmia

Eligibility:

All Genders

18-100 years

Brief Summary

In a cohort of patients electively treated for atrial arrhythmia with IV sotalol (initiation or dose escalation), this study will describe patient characteristics, short-term safety and efficacy, elec...

Detailed Description

Antiarrhythmic drug therapy plays a vital role in the achievement of rhythm control in patients with atrial arrhythmias. Class III antiarrhythmic drugs are frequently used in these patients. However, ...

Eligibility Criteria

Inclusion

  • Adults age 18 years and older
  • Eligible for the use of elective intravenous sotalol loading to treat atrial arrhythmias, per the treating clinician
  • IV sotalol infusion started for the treatment of atrial arrhythmias, in the setting of initiation or dose titration of chronic sotalol therapy
  • Elective hospital admission primarily for loading with intravenous sotalol with/without cardioversion, with no other planned therapy or procedures

Exclusion

  • Study materials not available in the subject's preferred language.
  • Patients undergoing treatment for active concomitant ventricular arrhythmias
  • Standard exclusions for elective sotalol use (at the time of initiation):
  • Heart rate \< 40 bpm or 2nd/3rd degree AV block without pacemaker
  • QTc ≥ 450 in absence of bundle branch block (≥ 500 in the presence of a bundle branch block)
  • Severe left ventricular hypertrophy (thickness \>1.5 cm)
  • Patients who were previously intolerant to antiarrhythmic class III therapy
  • Patients missing key data elements in their electronic health record (for retrospective subjects only).

Key Trial Info

Start Date :

February 4 2022

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 30 2023

Estimated Enrollment :

167 Patients enrolled

Trial Details

Trial ID

NCT05247320

Start Date

February 4 2022

End Date

August 30 2023

Last Update

September 26 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Utah

Salt Lake City, Utah, United States, 84112